GCM
HALO icon

Graham Capital Management’s Halozyme HALO Stock Holding History

Graham Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,094
Closed -$447K – 1374
2025
Q3 		$447K Buy
+6,094
New +$405K 0.01% 659
2024
Q1 		– Sell
-19,422
Closed -$718K – 1161
2023
Q4 		$718K Buy
+19,422
New +$732K 0.02% 478

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Graham Capital Management's HALO Position: Q4 2025 in Review

Graham Capital Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 6,094 shares — an estimated $447K sold.

Graham Capital Management first reported a position in HALO in Q4 2023 and held it in 2 quarters. The position peaked at $718K in Q4 2023. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Graham Capital Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 6,094 Halozyme shares in Q4 2025, an estimated $447K.
  • Graham Capital Management first reported a position in Halozyme in Q4 2023 and held it in 2 quarters.
  • Graham Capital Management's Halozyme position peaked at $718K in Q4 2023.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.